Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A. (November 2016)
- Record Type:
- Journal Article
- Title:
- Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A. (November 2016)
- Main Title:
- Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A
- Authors:
- Kosmidis, Georgios
Veerman, Christiaan C.
Casini, Simona
Verkerk, Arie O.
van de Pas, Simone
Bellin, Milena
Wilde, Arthur A.M.
Mummery, Christine L.
Bezzina, Connie R. - Abstract:
- Abstract : Background—: Several compounds have been reported to induce translational readthrough of premature stop codons resulting in the production of full-length protein by interfering with ribosomal proofreading. Here we examined the effect of 2 of these compounds, gentamicin and PTC124, in human-induced pluripotent stem cell (hiPSC)–derived cardiomyocytes bearing nonsense mutations in the sodium channel gene SCN5A, which are associated with conduction disease and potential lethal arrhythmias. Methods and Results—: We generated hiPSC from 2 patients carrying the mutations R1638X and W156X. hiPSC-derived cardiomyocytes from both patients recapitulated the expected electrophysiological phenotype, as evidenced by reduced Na + currents and action potential upstroke velocities compared with hiPSC-derived cardiomyocytes from 2 unrelated control individuals. While we were able to confirm the readthrough efficacy of the 2 drugs in Human Embryonic Kidney 293 cells, we did not observe rescue of the electrophysiological phenotype in hiPSC-derived cardiomyocytes from the patients. Conclusions—: We conclude that these drugs are unlikely to present an effective treatment for patients carrying the loss-of-function SCN5A gene mutations examined in this study. Abstract : Supplemental Digital Content is available in the text.
- Is Part Of:
- Circulation. Volume 9:Number 11(2016)
- Journal:
- Circulation
- Issue:
- Volume 9:Number 11(2016)
- Issue Display:
- Volume 9, Issue 11 (2016)
- Year:
- 2016
- Volume:
- 9
- Issue:
- 11
- Issue Sort Value:
- 2016-0009-0011-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-11
- Subjects:
- induced pluripotent stem cells -- mutation -- nonsense mutation -- readthrough -- SCN5A -- sodium channels
Arrhythmia -- Periodicals
Heart -- Electric properties -- Periodicals
616.128 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01337493-000000000-00000 ↗
http://circep.ahajournals.org/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/CIRCEP.116.004227 ↗
- Languages:
- English
- ISSNs:
- 1941-3149
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3265.262500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2340.xml